MFN Partners Management, LP is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.
Filed | Shares | Percentage | |
---|---|---|---|
Foley Trasimene Acquisition Corp. | March 15, 2021 | 5,000,000 | 4.8% |
Cyclerion Therapeutics, Inc. | February 12, 2021 | 2,427,677 | 7.2% |
Foley Trasimene Acquisition Corp. | February 12, 2021 | 14,000,000 | 13.5% |
Foley Trasimene Acquisition IISold out | February 12, 2021 | 0 | 0.0% |
Aclaris Therapeutics, Inc. | July 22, 2020 | 1,895,677 | 4.5% |